Monitoring G protein-coupled receptor activation using the protein fragment complementation technique split TEV

Michael C Wehr1, Sabrina Galinski, Moritz J Rossner

  • 1Molecular Neurobiology, Department of Psychiatry, Ludwig Maximilian University, Nußbaumstr. 7, 80336, Munich, Germany, Michael.Wehr@med.uni-muenchen.de.

Insights

Split TEV protease fragment complementation assays G protein-coupled receptor (GPCR) activity by monitoring β-arrestin binding. This sensitive method aids understanding GPCRs in health, disease, and drug development.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Pharmacology

Background:

  • G protein-coupled receptors (GPCRs) are crucial cell signaling regulators involved in diverse physiological processes.
  • GPCRs play roles in diseases like cancer and neurodevelopmental disorders, making them significant drug targets.
  • Understanding GPCR activity regulation is vital for physiological insights and drug development.

Purpose of the Study:

  • To introduce and validate Split TEV protease fragment complementation as a sensitive method for assaying GPCR activity.
  • To monitor GPCR interactions with β-arrestin in living cells.

Main Methods:

  • Utilized Split TEV, a technique based on TEV protease fragment complementation.
  • Fused GPCRs and β-arrestin to N- and C-terminal fragments of TEV protease.
  • Detected GPCR-β-arrestin interactions via fluorescence or luminescence reporters dependent on TEV cleavage.

Main Results:

  • Split TEV enables sensitive detection of GPCR activity through β-arrestin binding.
  • The method offers a two-step amplification for a robust readout.
  • Experimental procedures are adaptable, taking 24-72 hours.

Conclusions:

  • Split TEV is a versatile and sensitive tool for studying GPCR activity in living cells.
  • This assay facilitates research into GPCRs' physiological roles and therapeutic potential.
  • The method provides a robust platform for drug discovery targeting GPCRs.